DECADRON Side Effects

6734090-8 | Anaemia, Candidiasis, Hypocalcaemia, Hypomagnesaemia, Pancytopenia, Pneumonia, Renal Failure Acute, Vitamin D Deficiency
on May 17, 2010 Male patient from UNITED STATES , 58 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, candidiasis, hypocalcaemia, hypomagnesaemia, pancytopenia, pneumonia (What is pneumonia?), renal failure acute, vitamin d deficiency. Decadron dosage: 4mg Daily (20 Mg Every Monday). During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), XANAX (View Xanax Review and Xanax Label ), REVLIMID (Daily X 21 Days And 7 Days Off) (View Revlimid Review and Revlimid Label ), MORPHINE (View Morphine Review and Morphine Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.

6732399-5 | Aggression, Agitation, Insomnia, Irritability
Patient was taking Decadron (View Usage). Patient had the following side effects: aggression, agitation, insomnia, irritability on May 05, 2010 from UNITED STATES Additional patient health information: Male patient , child 10 years of age, was diagnosed with acute lymphocytic leukaemia and. Decadron dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

6726694-3 | Abnormal Behaviour, Affect Lability, Delusion, Flight Of Ideas, Insomnia, Irritability, Mania, Mood Altered, Personality Change
Adverse event was reported on May 05, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED STATES , 16 years of age, After Decadron was administered, patient had the following side effects: abnormal behaviour, affect lability, delusion, flight of ideas, insomnia, irritability, mania, mood altered, personality change.

6724218-8 | Ballismus, Encephalopathy, Neurotoxicity, Urinary Incontinence
on May 11, 2010 Female patient from UNITED STATES , child 7 years of age, was diagnosed with osteosarcoma metastatic and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: ballismus, encephalopathy, neurotoxicity, urinary incontinence (What is urinary incontinence?). Decadron dosage: . During the same period patient was treated with IFOSFAMIDE (2.8 G/m2 Over 4 Hr Daily For 5 Days) (View Ifosfamide Review and Ifosfamide Label ), MESNA (View Mesna Review and Mesna Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DRONABINOL (View Dronabinol Review and Dronabinol Label ).


6724216-4 | Anaemia, Decreased Appetite, Diarrhoea, Fatigue, Hepatic Enzyme Abnormal, Nausea, Thrombocytopenia, White Blood Cell Count Decreased
on May 07, 2010 Male patient from UNITED STATES , 69 years of age, weighting 238.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient had the following side effects: anaemia, decreased appetite, diarrhoea, fatigue, hepatic enzyme abnormal, nausea (What is nausea?), thrombocytopenia, white blood cell count decreased. Decadron dosage: Weekly On Fridays. During the same period patient was treated with REVLIMID (Daily X 21 Days, Off 7 Days) (View Revlimid Review and Revlimid Label ), VALTREX (View Valtrex Review and Valtrex Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6724207-3 | Ballismus, Encephalopathy
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: ballismus, encephalopathy on May 11, 2010 from UNITED STATES Additional patient health information: Male patient , 16 years of age, was diagnosed with bone sarcoma and. Decadron dosage: . During the same period patient was treated with IFOSFAMIDE (2.8 G/m2 Over 4 Hr Daily For 5 Days) (View Ifosfamide Review and Ifosfamide Label ), MESNA (View Mesna Review and Mesna Label ), DOLASETRON MESYLATE (View Dolasetron Mesylate Review and Dolasetron Mesylate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ).

6718672-5 | Asthenia, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hypoglycaemia, Hypotension, Pallor, Vomiting
Adverse event was reported on Apr 22, 2010 by a Male patient taking Decadron (View Usage) (Dosage: 18 Mg/po) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 66 years of age, weighting 218.0 lb, Patient experienced the following unwanted or unexpected effects: asthenia, gastrointestinal haemorrhage, haemoglobin decreased, hypoglycaemia, hypotension, pallor, vomiting. During the same period patient was treated with PLAVIX (Po) (View Plavix Review and Plavix Label ), DOCETAXEL (160 Mg/iv) (View Docetaxel Review and Docetaxel Label ), ASPIRIN TAB (Po) (View Aspirin Tab Review and Aspirin Tab Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), PRINIVIL (Po) (View Prinivil Review and Prinivil Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), OMEPRAZOLE (Po) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6707377-2 | Gastroenteritis, Gastrointestinal Haemorrhage, Hypoglycaemia, Hypotension
on Apr 22, 2010 Male patient from UNITED STATES , 66 years of age, weighting 218.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Decadron (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?), gastrointestinal haemorrhage, hypoglycaemia, hypotension. Decadron dosage: 18 Mg/po. During the same period patient was treated with PLAVIX (Po) (View Plavix Review and Plavix Label ), DOCETAXEL (160 Mg/iv) (View Docetaxel Review and Docetaxel Label ), ASPIRIN TAB (Po) (View Aspirin Tab Review and Aspirin Tab Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), LISINOPRIL (Po) (View Lisinopril Review and Lisinopril Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), OMEPRAZOLE (Po) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6704359-1 | Diabetic Ketoacidosis
on Apr 21, 2010 Female patient from JAPAN , 49 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: diabetic ketoacidosis. Decadron dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.

6701162-3 | Blood Potassium Decreased, Candidiasis, Deep Vein Thrombosis, Pulmonary Embolism
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, candidiasis, deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) on Apr 20, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), epiglottic carcinoma, pancreatic carcinoma, complex regional pain syndrome (What is complex regional pain syndrome?) and. Decadron dosage: For 3 Weeks And 4th Week Off. During the same period patient was treated with REVLIMID (For 21 Days, Off For 7 Days) (View Revlimid Review and Revlimid Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), XELODA (Mon-fri) (View Xeloda Review and Xeloda Label ), NEXIUM (View Nexium Review and Nexium Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

6695295-8 | Acute Respiratory Failure, Calcification Metastatic, Hypercalcaemia, Hypocalcaemia, Marrow Hyperplasia, Multi-organ Failure, Pulmonary Calcification
Adverse event was reported on Apr 15, 2010 by a Female patient taking Decadron (View Usage) (Dosage: ) was diagnosed with light chain disease, thrombosis, helicobacter gastritis, nephropathy and. Location: ITALY , 60 years of age, Patient had the following side effects: acute respiratory failure, calcification metastatic, hypercalcaemia, hypocalcaemia, marrow hyperplasia, multi-organ failure, pulmonary calcification. During the same period patient was treated with LENALIDOMIDE (View Lenalidomide Review and Lenalidomide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), SALINA (View Salina Review and Salina Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), BICARBONATE (View Bicarbonate Review and Bicarbonate Label ), ZOLEDRONATE DISODIUM (View Zoledronate Disodium Review and Zoledronate Disodium Label ). Patient was hospitalized.

6691006-0 | Cerebral Haemorrhage, Hyperglycaemia, Hyponatraemia
on Apr 19, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: cerebral haemorrhage, hyperglycaemia, hyponatraemia. Decadron dosage: . During the same period patient was treated with REVLIMID (21/28days) (View Revlimid Review and Revlimid Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), PROTONIX (View Protonix Review and Protonix Label ), REGLAN (View Reglan Review and Reglan Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6686759-1 | Mucosal Inflammation, Oesophageal Candidiasis, Oesophageal Stenosis, Oral Candidiasis, Weight Decreased
on Apr 09, 2010 Male patient from IRELAND , child 4 years of age, was diagnosed with b-cell type acute leukaemia and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: mucosal inflammation, oesophageal candidiasis, oesophageal stenosis, oral candidiasis, weight decreased. Decadron dosage: . During the same period patient was treated with DAUNORUBICIN (View Daunorubicin Review and Daunorubicin Label ), PEGYLATED DOCETAXEL (View Pegylated Docetaxel Review and Pegylated Docetaxel Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6686756-6 | Oesophageal Stenosis
Patient was taking Decadron (View Usage). Patient had the following side effects: oesophageal stenosis on Apr 09, 2010 from IRELAND Additional patient health information: Male patient , child 11 years of age, was diagnosed with b-cell type acute leukaemia and. Decadron dosage: . During the same period patient was treated with DAUNORUBICIN (View Daunorubicin Review and Daunorubicin Label ), PEGYLATED DOCETAXEL (View Pegylated Docetaxel Review and Pegylated Docetaxel Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6682025-9 | Discomfort, Erythema, Feeling Hot, Hyperaesthesia, Insomnia, Local Swelling, Muscle Spasms, Muscle Twitching
Adverse event was reported on Apr 14, 2010 by a Female patient taking Decadron (View Usage) (Dosage: 2 Iv) was diagnosed with migraine (What is migraine?) and. Location: UNITED STATES , 60 years of age, weighting 150.0 lb, After Decadron was administered, patient had the following side effects: discomfort, erythema, feeling hot, hyperaesthesia, insomnia, local swelling, muscle spasms, muscle twitching.

6681484-5 | Anaemia, Colitis, Neutropenia, Neutropenic Sepsis, Septic Shock
on Apr 06, 2010 Male patient from UNITED STATES , 59 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, colitis, neutropenia, neutropenic sepsis, septic shock. Decadron dosage: . During the same period patient was treated with REVLIMID (Daily X 21 Days / Off 1 Week) (View Revlimid Review and Revlimid Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6679740-X | Febrile Neutropenia
on Apr 07, 2010 Male patient from NETHERLANDS , 37 years of age, was diagnosed with astrocytoma and was treated with Decadron (View Usage). Patient had the following side effects: febrile neutropenia. Decadron dosage: . During the same period patient was treated with LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), VALPROAT (View Valproat Review and Valproat Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), LOMUSTINE (View Lomustine Review and Lomustine Label ), PROCARBAZINE (View Procarbazine Review and Procarbazine Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6677181-2 | Pneumocystis Jiroveci Pneumonia
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: pneumocystis jiroveci pneumonia on Apr 05, 2010 from GREECE Additional patient health information: Female patient , 64 years of age, was diagnosed with anaplastic astrocytoma and. Decadron dosage: . During the same period patient was treated with TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ). Patient was hospitalized.

6675026-8 | Phaeochromocytoma Crisis
Adverse event was reported on Mar 31, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with cushing's syndrome, diabetes mellitus, hypertension and. Location: JAPAN , 53 years of age, weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: phaeochromocytoma crisis. During the same period patient was treated with NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), NOVORAPID (10-8-8) (View Novorapid Review and Novorapid Label ), LEVEMIR (View Levemir Review and Levemir Label ).

6663901-X | Cellulitis Gangrenous, Disseminated Intravascular Coagulation, Gastritis Erosive, Gastrointestinal Haemorrhage, Hyperglycaemia, Hyponatraemia, Septic Shock
on Mar 22, 2010 Male patient from UNITED STATES , 53 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient had the following side effects: cellulitis gangrenous, disseminated intravascular coagulation, gastritis erosive, gastrointestinal haemorrhage, hyperglycaemia, hyponatraemia, septic shock. Decadron dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6663862-3 | Phaeochromocytoma Crisis
on Mar 24, 2010 Male patient from JAPAN , 53 years of age, weighting 121.3 lb, was diagnosed with cushing's syndrome, diabetes mellitus, hypertension and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: phaeochromocytoma crisis. Decadron dosage: . During the same period patient was treated with NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), NOVORAPID (10-8-8) (View Novorapid Review and Novorapid Label ), LEVEMIR (View Levemir Review and Levemir Label ).

6661448-8 | Haemoglobin Decreased, Neutrophil Count Decreased, Personality Change, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, neutrophil count decreased, personality change, platelet count decreased, white blood cell count decreased on Mar 24, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 216.1 lb, was diagnosed with diarrhoea, multiple myeloma (What is multiple myeloma?) and. Decadron dosage: . During the same period patient was treated with THALOMID (View Thalomid Review and Thalomid Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ).

6658079-2 | Hyponatraemia
Adverse event was reported on Mar 18, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with fatigue, routine health maintenance, pain (What is pain?), deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?), constipation (What is constipation?) and. Location: UNITED KINGDOM , 46 years of age, Patient had the following side effects: hyponatraemia. During the same period patient was treated with MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), WARFARIN (View Warfarin Review and Warfarin Label ), MOVICOL (View Movicol Review and Movicol Label ). Patient was hospitalized.

6654677-0 | Psychotic Disorder
on Mar 17, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Decadron dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6651173-1 | Condition Aggravated, Multiple Myeloma
on Mar 10, 2010 Male patient from KOREA, REPUBLIC OF , 62 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, multiple myeloma (What is multiple myeloma?). Decadron dosage: 20 Mg/daily. During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), VORINOSTAT (View Vorinostat Review and Vorinostat Label ). Patient was hospitalized.

6651138-X | Diabetes Mellitus Inadequate Control, Metastases To Bone, Metastases To Liver, Pneumonia, Treatment Noncompliance, Vaginitis Bacterial
Patient was taking Decadron (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, metastases to bone, metastases to liver, pneumonia (What is pneumonia?), treatment noncompliance, vaginitis bacterial on Mar 18, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 224.0 lb, was diagnosed with type 1 diabetes mellitus and. Decadron dosage: 8 Mg/q8h/po. During the same period patient was treated with MEMANTINE HCL (Po) (View Memantine Hcl Review and Memantine Hcl Label ), NOVOLOG (50 Units/am/sc; 50 Units/am) (View Novolog Review and Novolog Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), VERAPAMIL ER (View Verapamil Er Review and Verapamil Er Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ). Patient was hospitalized.

6651129-9 | Abnormal Behaviour, Agitation, Delusion, Haemoglobin Decreased, Nuclear Magnetic Resonance Imaging Brain Abnormal, Personality Change, Thrombocytopenia
Adverse event was reported on Mar 16, 2010 by a Male patient taking Decadron (View Usage) (Dosage: Po) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 48 years of age, weighting 200.0 lb, After Decadron was administered, patient had the following side effects: abnormal behaviour, agitation, delusion, haemoglobin decreased, nuclear magnetic resonance imaging brain abnormal, personality change, thrombocytopenia. During the same period patient was treated with CAP VORINOSTAT UNK (400 Mg/daily/po) (View Cap Vorinostat Unk Review and Cap Vorinostat Unk Label ), VELCADE (1.3 Mg/m[2] Iv) (View Velcade Review and Velcade Label ). Patient was hospitalized.

6651128-7 | Acute Prerenal Failure, Alanine Aminotransferase Increased, Asthenia, Dehydration, Dyspnoea Exertional, Fatigue, Lung Cancer Metastatic
on Mar 16, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with lung neoplasm malignant, pain (What is pain?), abdominal discomfort, cognitive disorder, prophylaxis and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, alanine aminotransferase increased, asthenia, dehydration, dyspnoea exertional, fatigue, lung cancer metastatic. Decadron dosage: 4 Mg/daily/po. During the same period patient was treated with DARVOCET N 100 (100 Mg/q4h/po) (View Darvocet-n 100 Review and Darvocet-n 100 Label ), PRILOSEC (20 Mg/bid/po) (View Prilosec Review and Prilosec Label ), ATIVAN (1 Mg/daily/iv, 1 Mg/prn/po) (View Ativan Review and Ativan Label ). Patient was hospitalized.

6649776-3 | Agitation, Delusion, Haemoglobin Decreased, Personality Change, Platelet Count Decreased
on Mar 02, 2010 Male patient from UNITED STATES , 48 years of age, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with Decadron (View Usage). Patient had the following side effects: agitation, delusion, haemoglobin decreased, personality change, platelet count decreased. Decadron dosage: Po. During the same period patient was treated with CAP VORINOSTAT UNK (400 Mg Daily Po) (View Cap Vorinostat Unk Review and Cap Vorinostat Unk Label ), VELCADE (1.3 Mg/m[2] Iv) (View Velcade Review and Velcade Label ). Patient was hospitalized.

6646790-9 | Muscle Atrophy, Muscular Weakness
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: muscle atrophy, muscular weakness on Mar 16, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 132.3 lb, was diagnosed with prostate cancer (What is prostate cancer?), prophylaxis against gastrointestinal ulcer and. Decadron dosage: . During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), GABAPEN (View Gabapen Review and Gabapen Label ). Patient was hospitalized and became disabled.

6644641-X | Phaeochromocytoma
Adverse event was reported on Mar 16, 2010 by a Female patient taking Decadron (View Usage) (Dosage: ) was diagnosed with adrenal neoplasm and. Location: KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF , 61 years of age, Patient experienced the following unwanted or unexpected effects: phaeochromocytoma.

6642638-7 | Cd4 Lymphocytes Decreased, Respiratory Moniliasis, Skin Exfoliation, Stridor
on Mar 10, 2010 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with prophylaxis of nausea and vomiting, anal cancer (What is anal cancer?) and was treated with Decadron (View Usage). Patient had the following side effects: cd4 lymphocytes decreased, respiratory moniliasis, skin exfoliation, stridor. Decadron dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), MITOMYCIN (View Mitomycin Review and Mitomycin Label ).

6640578-0 | Cellulitis, Disease Recurrence, Gastroenteritis Salmonella, Hepatitis, Multiple Myeloma, Necrotising Fasciitis, Pathological Fracture, Plasmacytoma, Proteus Infection
on Mar 10, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), splinter, cellulitis (What is cellulitis?), sepsis (What is sepsis?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: cellulitis (What is cellulitis?), disease recurrence, gastroenteritis salmonella, hepatitis (What is hepatitis?), multiple myeloma (What is multiple myeloma?), necrotising fasciitis, pathological fracture, plasmacytoma, proteus infection. Decadron dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), FLOXACILLIN (View Floxacillin Review and Floxacillin Label ), PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ). Patient was hospitalized.

6640519-6 | Empyema
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: empyema on Mar 10, 2010 from TURKEY Additional patient health information: Male patient , weighting 2.20 lb, was diagnosed with chronic respiratory disease and. Decadron dosage: .

6638539-0 | Ballismus, Encephalopathy
Adverse event was reported on Mar 10, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with bone sarcoma and. Location: UNITED STATES , 16 years of age, Patient had the following side effects: ballismus, encephalopathy. During the same period patient was treated with IFOSFAMIDE (2.8 G/m2 Over 4 Hr Daily For 5 Days) (View Ifosfamide Review and Ifosfamide Label ), MESNA (View Mesna Review and Mesna Label ), DOLASETRON MESYLATE (View Dolasetron Mesylate Review and Dolasetron Mesylate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ).

6638495-5 | Ballismus, Encephalopathy
on Mar 10, 2010 Female patient from UNITED STATES , child 7 years of age, was diagnosed with osteosarcoma metastatic and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: ballismus, encephalopathy. Decadron dosage: . During the same period patient was treated with IFOSFAMIDE (2.8 G/m2 Over 4 Hr Daily For 5 Days) (View Ifosfamide Review and Ifosfamide Label ), MESNA (View Mesna Review and Mesna Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DRONABINOL (View Dronabinol Review and Dronabinol Label ).

6635586-X | Angina Pectoris, Myocardial Infarction
on Mar 09, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, myocardial infarction. Decadron dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ).

6632380-0 | Completed Suicide, Depressive Symptom
Patient was taking Decadron (View Usage). Patient had the following side effects: completed suicide, depressive symptom on Mar 03, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer (What is breast cancer?) and. Decadron dosage: . During the same period patient was treated with GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ).

6632367-8 | Pulmonary Alveolar Haemorrhage, Strongyloidiasis
Adverse event was reported on Mar 03, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?), strongyloidiasis, pneumonia (What is pneumonia?) and. Location: JAPAN , 75 years of age, After Decadron was administered, patient had the following side effects: pulmonary alveolar haemorrhage, strongyloidiasis. During the same period patient was treated with STROMECTOL (View Stromectol Review and Stromectol Label ), PIPERACILLIN SODIUM (View Piperacillin Sodium Review and Piperacillin Sodium Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).

6631113-1 | Abnormal Behaviour, Agitation, Delusion, Haemoglobin Decreased, Thrombocytopenia
on Mar 02, 2010 Male patient from UNITED STATES , 48 years of age, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, agitation, delusion, haemoglobin decreased, thrombocytopenia. Decadron dosage: Po. During the same period patient was treated with CAP VORINOSTAT UNK (400 Mg/daily/po) (View Cap Vorinostat Unk Review and Cap Vorinostat Unk Label ), VELCADE (1.3 Mg/m[2]/iv) (View Velcade Review and Velcade Label ). Patient was hospitalized.

6610970-9 | Alanine Aminotransferase Increased, Arteritis, Aspartate Aminotransferase Increased, Atelectasis, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Condition Aggravated, Fatigue, Haemoglobin Decreased
on Feb 16, 2010 Male patient from CANADA , 48 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Decadron (View Usage). Patient had the following side effects: alanine aminotransferase increased, arteritis, aspartate aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, fatigue, haemoglobin decreased. Decadron dosage: Po. During the same period patient was treated with GEMZAR (Iv) (View Gemzar Review and Gemzar Label ), CISPLATIN (Iv) (View Cisplatin Review and Cisplatin Label ), RITUXIMAB (Iv) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6597787-9 | Activities Of Daily Living Impaired, Acute Prerenal Failure, Dehydration, Fatigue, Troponin I Increased, Weight Decreased
Patient was taking Decadron (View Usage). After Decadron was administered, patient had the following side effects: activities of daily living impaired, acute prerenal failure, dehydration, fatigue, troponin i increased, weight decreased on Feb 05, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 134.0 lb, was diagnosed with lung neoplasm malignant, pain (What is pain?), abdominal discomfort, cognitive disorder, prophylaxis and. Decadron dosage: 4 Mg/daily/po. During the same period patient was treated with DARVOCET N 100 (100 Mg/q4h/po) (View Darvocet-n 100 Review and Darvocet-n 100 Label ), PRILOSEC (20 Mg/bid/po) (View Prilosec Review and Prilosec Label ), ATIVAN (1 Mg/daily/iv; 1 Mg/prn/iv) (View Ativan Review and Ativan Label ). Patient was hospitalized.

6596754-9 | Dry Mouth, Muscle Spasms, Palpitations, Thrombophlebitis, Tremor
Adverse event was reported on Feb 15, 2010 by a Female patient taking Decadron (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), pulmonary embolism (What is pulmonary embolism?), deep vein thrombosis (What is deep vein thrombosis?) and. Location: CANADA , 63 years of age, Patient experienced the following unwanted or unexpected effects: dry mouth, muscle spasms, palpitations, thrombophlebitis, tremor. During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), AREDIA (View Aredia Review and Aredia Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6580075-4 | Zygomycosis
on Feb 02, 2010 Male patient from UNITED STATES , child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Decadron (View Usage). Patient had the following side effects: zygomycosis. Decadron dosage: .

6575668-4 | Oedema Peripheral, Renal Failure
on Oct 16, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: oedema peripheral, renal failure. Decadron dosage: . During the same period patient was treated with THALOMID (View Thalomid Review and Thalomid Label ), LASIX (View Lasix Review and Lasix Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLOMAX (View Flomax Review and Flomax Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).

6574371-4 | Asthenia, Flushing, Hypocalcaemia, Pancytopenia
Patient was taking Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, flushing, hypocalcaemia, pancytopenia on Jan 29, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), myelodysplastic syndrome, metastases to bone and. Decadron dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), ARANESP (View Aranesp Review and Aranesp Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6572470-4 | Colon Cancer, Diabetic Ketoacidosis
Adverse event was reported on Feb 01, 2010 by a Male patient taking Decadron (View Usage) (Dosage: ) was diagnosed with nausea (What is nausea?) and. Location: JAPAN , 76 years of age, Patient had the following side effects: colon cancer, diabetic ketoacidosis. During the same period patient was treated with DEXART (View Dexart Review and Dexart Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6558368-6 | Muscle Atrophy, Muscular Weakness, Parkinson's Disease, Restless Legs Syndrome, Sleep Disorder
on Jan 19, 2010 Male patient from JAPAN , 70 years of age, weighting 59.52 lb, was diagnosed with prostate cancer (What is prostate cancer?), prophylaxis against gastrointestinal ulcer and was treated with Decadron (View Usage). After Decadron was administered, patient had the following side effects: muscle atrophy, muscular weakness, parkinson's disease (What is parkinson's disease?), restless legs syndrome, sleep disorder (What is sleep disorder?). Decadron dosage: . During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), GABAPEN (View Gabapen Review and Gabapen Label ). Patient was hospitalized and became disabled.

6558365-0 | Strongyloidiasis
on Jan 21, 2010 Male patient from QATAR , 39 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), spinal cord compression and was treated with Decadron (View Usage). Patient experienced the following unwanted or unexpected effects: strongyloidiasis. Decadron dosage: . Patient was hospitalized.

6558360-1 | Diabetic Ketoacidosis
Patient was taking Decadron (View Usage). Patient had the following side effects: diabetic ketoacidosis on Jan 20, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with nausea (What is nausea?) and. Decadron dosage: . During the same period patient was treated with DECADRON PHOSPHATE (View Decadron Phosphate Review and Decadron Phosphate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.